Search
Loading Complete
Marilyn Albert

Marilyn Albert, PhD

Highlights

Languages

  • English

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Marilyn Albert

Professional Titles

  • Director of Cognitive Neuroscience, Department of Neurology

Primary Academic Title

Professor of Neurology

Background

Marilyn Albert is professor of neurology at Johns Hopkins and director of the Division of Cognitive Neuroscience. Dr. Albert focuses on the cognitive and brain changes associated with aging and Alzheimer’s disease (AD). Her work has delineated the cognitive changes associated with aging and early AD, along with potential methods of early identification of AD. She has also identified lifestyle factors that promote maintenance of mental abilities with advancing age.

Dr. Albert’s research currently focuses on the early identification of AD, and potential ways of monitoring the progression of disease to permit early intervention.

Dr. Albert received her doctorate in physiological psychology from McGill University in Montreal and completed a fellowship in neuropsychology at Boston University School of Medicine. She served on the faculty of the Harvard Medical School for over 22 years.

Centers and Institutes

Alzheimer's Disease Research Center

Clinical Trials Summary

Alzheimer’s Disease Neuroimaging Initiative

Videos

Recent News Articles and Media Coverage

  • Changing the Future of Aging, Doorways to Discovery (November 2014)

    An Alzheimer's Early Warning? NeuroLogic (Summer 2014)

Additional Academic Titles

Professor of Neuroscience, Professor of Pathology, Professor of Psychiatry and Behavioral Sciences

Contact for Research Inquiries

Department of Neurology
1620 McElderry Street
Baltimore, MD 21287

Phone: (410) 614-3040
Fax: (410) 502-2189
malbert9@jhmi.edu

Lab Website

Alzheimer's Disease Research Center - Lab Website

  • The goal of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) is to accelerate the discovery of new treatments that are directed at the basic mechanisms of disease, and to hasten the time when effective treatments for AD and related disorders become a reality. We have a strong commitment to basic research regarding the underlying mechanisms of Alzheimer's Disease and related disorders, and how this may translate into effective treatment. We perform clinical research seeking to identify medications to delay or treat the symptoms of dementia. We also provided many educational programs for family members and professionals.

Research Summary

  • Major research interests are in the area of cognitive change with age
  • Disease-related changes of cognition (with a particular focus on Alzheimer's Disease)
  • The relationship of cognitive change to brain structure and function, as assessed through imaging (e.g., MRI, fMRI, SPECT) and genetics
  • Recent studies have focused on how to predict who will develop Alzheimer's disease over time
  • Additional research efforts have included epidemiological studies of predictors of the maintenance of cognitive function, as well as cognitive decline

Google Scholar

http://scholar.google.com/scholar?q=Albert+MS&btnG=&hl=en&as_sdt=0%2C21

PubMed

http://www.ncbi.nlm.nih.gov/pubmed/?term=Albert+MS

Selected Publications

  • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270-279.

  • Bakker A, Kraus G, Albert M, Speck C, Jones L, Stark C, Yassa M, Bassett S, Shelton A, Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 2012; 74: 467-474.

  • Blacker D, Lee H, Muzikansky A, Martin E, Tanzi R, McArdle J, Moss M, Albert M. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol, 2007; 64: 862-871.

  • Dickerson B, Stoub T, Shah R, Sperling R, Killiany R, Albert M, Hyman B, Blacker D, Detoledo-Morrell L. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurol 2011; 76: 1395-1402.

  • Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O'Brien R, BIOCARD Research Team. Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiol Aging. 2013; 34: 2827-2834.

  • Yassa M, Stark C, Bakker A, Albert M, Gallagher M, Stark C. High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment. Neuroimage 2010; 51: 1242-1252.

Lectures & Presentations